Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Louis Leone

Psychiatry Virginia Beach, VA Medical Doctor

NPI 1558522631 CMS profile 24898

4509 Whitechapel Dr, Virginia Beach, VA 23455

Open in the dashboard

General payments

$999

54 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Louis Leone of Virginia Beach, VA is reported in the CMS Open Payments database as having received $999 across 54 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $116 4
2024 General $77 3
2023 General $312 17
2022 General $234 15
2021 General $28 1
2020 General $108 6
2019 General $123 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Louis Leone
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Louis Leone were reported at $116. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Louis Leone Psychiatry median Middle half National median
2019 $123 $184 $59–$605 $163
2020 $108 $119 $36–$372 $114
2021 $28 $143 $43–$576 $132
2022 $234 $153 $50–$590 $149
2023 $312 $170 $56–$651 $160
2024 $77 $179 $57–$673 $164
2025 $116 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $226 14 payments
  2. Janssen Pharmaceuticals, Inc $176 7 payments
  3. Sunovion Pharmaceuticals Inc. $143 10 payments
  4. Otsuka America Pharmaceutical, Inc. $130 7 payments
  5. Neurocrine Biosciences, Inc. $83 5 payments
  6. E.R. Squibb & Sons, L.L.C. $81 3 payments
  7. Alkermes, Inc. $73 3 payments
  8. ITI, Inc. $37 2 payments
  9. Teva Pharmaceuticals USA, Inc. $26 1 payment
  10. Allergan Inc. $24 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $999 54 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR $226 14 payments
  2. INVEGA SUSTENNA $176 7 payments
  3. LATUDA $143 10 payments
  4. ABILIFY MAINTENA $130 7 payments
  5. REXULTI $107 6 payments
  6. INVEGA TRINZA $81 4 payments
  7. COBENFY $55 2 payments
  8. INGREZZA $54 3 payments
  9. LYBALVI $49 2 payments
  10. CAPLYTA $37 2 payments
  11. Other $322 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 57 drugs

Part D claims

1,620

Median for Psychiatry: 574

Drug cost

$591,318

Median for Psychiatry: $27,624

Branded share of claims

25.2%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Sustenna Paliperidone Palmitate Brand 59 $209,009
Invega Trinza Paliperidone Palmitate Brand 14 $129,876
Austedo Deutetrabenazine Brand 12 $68,145
Uzedy Risperidone Brand 18 $64,363
Abilify Maintena Aripiprazole Brand 20 $50,258
Vraylar Cariprazine Hcl Brand 17 $23,652
Trintellix Vortioxetine Hydrobromide Brand 15 $8,280
Paliperidone Er Paliperidone Brand 14 $7,225
Aripiprazole Generic 48 $4,828
Clozapine Generic 29 $4,335

The 10 drugs with the highest cost, of 57 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$37,455

Medicare's payments for the services billed

Medicare patients

161

Average age 55

Services billed

706

76 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 52%
Depression 45%
Diabetes 24%
Arthritis 24%
COPD 16%
Chronic kidney disease 11%
Heart failure 7%
Ischemic heart disease 7%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
COBENFY
  • E.R. Squibb & Sons, L.L.C. $27
$27 — —
UZEDY
  • Teva Pharmaceuticals USA, Inc. $26
$26 18 —
ARISTADA
  • Alkermes, Inc. $19
$19 — —
LYBALVI
  • Alkermes, Inc. $5
$5 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record